Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,369
Recruiting: 3,967
Ph III recruiting: 537
Growth YoY: +9.4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,405)

clinicaltrialsPublishedShowing 8,501–8,550 of 8,903 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03319628	First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b	active not recruiting	Phase 1 / Phase 2	523	Mersana TherapeuticsINDUSTRY	1	Nov 13, 2023	clinicaltrials
NCT06126406	Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors	recruiting	Phase 1	60	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Nov 13, 2023	clinicaltrials